Johnson & Johnson (JNJ) Revenue (2009 - 2026)

Johnson & Johnson has disclosed Revenue across 18 years of filings, most recently posting $25.3 billion for Q2 2026.

• In Q2 2026, Revenue rose 6.6% year-over-year to $25.3 billion; the TTM figure through Jun 2026 stood at $97.9 billion (up 8.06% YoY), while the FY2025 annual figure was $94.2 billion, up 6.05% from the prior year.
• Revenue came in at $25.3 billion for Q2 2026 at Johnson & Johnson, up from $24.1 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $25.3 billion in Q2 2026 to a low of $19.8 billion in Q2 2022.
• Average Revenue over 5 years is $22.1 billion, with a median of $21.7 billion recorded in 2023.
• Year-over-year, Revenue dropped 14.32% in 2022 and advanced 9.91% in 2026.
• Over 5 years, Revenue stood at $20.0 billion in 2022, then gained by 7.0% to $21.4 billion in 2023, then grew by 5.26% to $22.5 billion in 2024, then grew by 9.08% to $24.6 billion in 2025, then rose by 3.04% to $25.3 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $25.3 billion in Q2 2026, $24.1 billion in Q1 2026, and $24.6 billion in Q4 2025.